Copertina

Correction to ‘Hourglass, a compass navigating global and regional heterogeneity of pancreatic cancer’

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	The Journal of Pathology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Redefining phenotypic intratumor heterogeneity of pancreatic ductal adenocarcinoma: a bottom‐up approach
di: Marc Hilmi, et al.
Pubblicazione: (2025)

Metamorphoses in pancreatic cancer precursors: the role of simple mucinous cysts †
di: Paolo Riccardo Camisa, et al.
Pubblicazione: (2025)

Spatial heterogeneity of antibody–drug conjugate targets in pancreatic ductal adenocarcinoma
di: Deema Sabtan, et al.
Pubblicazione: (2026)

Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization
di: Antonio Pea, et al.
Pubblicazione: (2025)

Assessing spatial sequencing and imaging approaches to capture the molecular and pathological heterogeneity of archived cancer tissues
di: Tuan Vo, et al.
Pubblicazione: (2025)

Disrupted endocannabinoid signaling contributes to systemic inflammation in acute pancreatitis
di: Paula Goncalves‐Romeu, et al.
Pubblicazione: (2026)

Cancer‐associated fibroblast heterogeneity in chordoma†
di: Jack C Henry, et al.
Pubblicazione: (2025)

Genomic analysis defines distinct pancreatic and neuronal subtypes of lung carcinoid
di: Clara Domingo‐Sabugo, et al.
Pubblicazione: (2024)

Utility of pancreatic tumor scrapings for organoid development and precision medicine strategies
di: Caitlin F Tsang, et al.
Pubblicazione: (2026)

The importance of tumor microenvironment modulations in the progression of pancreatic intraductal papillary mucinous neoplasms†
di: Antonio Pea, et al.
Pubblicazione: (2025)

Should we worry about high‐grade pancreatic neuroendocrine tumor progression and alkylating agents?†
di: Wenzel M Hackeng, et al.
Pubblicazione: (2025)

Unveiling the intriguing relationship: oncogenic KRAS, morphological shifts, and mutational complexity in pancreatic mucinous cystic neoplasms
di: Lucas‐Alexander Schulte, et al.
Pubblicazione: (2025)

Correction to “Diverse landscape of dermatologic toxicities from small‐molecule inhibitor cancer therapy”
Pubblicazione: (2024)

New analysis of atypical spermatocytic tumours reveals extensive heterogeneity and plasticity of germ cell tumours †
di: Ewa Rajpert‐De Meyts, et al.
Pubblicazione: (2024)

Immunological mechanisms underlying the clinical heterogeneity of Kikuchi disease: the potential role of atypical memory B cells
di: Shan‐Chi Yu, et al.
Pubblicazione: (2026)

Tissue‐level heterogeneity in FECD : Descemet's membrane phenotypes and association with TCF4 CTG18 .1 expansion †
di: Sayo Maeno, et al.
Pubblicazione: (2026)

Xenium‐based spatial transcriptomic analyses uncover prognosis‐associated heterogeneity in the tumor microenvironment ( TME ) of angioimmunoblastic T‐cell lymphoma ( AITL )
di: Jiyan Dong, et al.
Pubblicazione: (2026)

Comparative transcriptomics of salivary basal cell adenoma and adenocarcinoma sustain linear neoplastic evolution and intertumor heterogeneity: classification and biological implications
di: Yoshitsugu Mitani, et al.
Pubblicazione: (2025)

Evaluation of pancreatic cancer specimens for comprehensive genomic profiling
di: Kota Washimi, et al.
Pubblicazione: (2024)

Mutational profile of the KIT gene and its heterogeneity in primary and metastatic melanomas
di: Jesús José André Quintana Castillo, et al.
Pubblicazione: (2024)

Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR‐mutated lung cancer treated with the first‐/second‐generation tyrosine kinase inhibitors
di: Michael Menzel, et al.
Pubblicazione: (2024)

Extracellular matrix cancer‐associated fibroblasts promote stromal fibrosis and immune exclusion in triple‐negative breast cancer
di: Xunxi Lu, et al.
Pubblicazione: (2025)

The road to therapy for myeloid sarcoma: navigating the complexities of subclonal MAPK / ERK mutations and clonal evolution
di: DuJiang Yang, et al.
Pubblicazione: (2025)

Upcycling HOXB13 : enhancing prostate cancer detection with a novel antibody †
di: Anke Augspach, et al.
Pubblicazione: (2024)

AMIGO2 characterizes cancer‐associated fibroblasts in metastatic colon cancer and induces the release of paracrine active tumorigenic secretomes
di: Yongsong Yong, et al.
Pubblicazione: (2024)

Mitochondrial reprogramming in lung cancer: a therapeutic vulnerability and a strategy for reversing drug resistance
di: Woo Hyun Park
Pubblicazione: (2026)

Subtype‐associated complexity and prognostic significance of the NLRP3 inflammasome landscape in pancreatic neoplasms
di: Kristóf Németh, et al.
Pubblicazione: (2025)

Revisionist history uncovers a simplified molecular‐based classification of differentiated thyroid cancer
di: Sylvia L Asa, et al.
Pubblicazione: (2025)

Delta‐like 1 homolog ( DLK1 ) regulates cancer stemness and chemoresistance of ovarian cancer by CD44 / CD133 upregulation
di: Chao‐Cheng Huang, et al.
Pubblicazione: (2026)

Clonal analysis of metachronous double biliary tract cancers
di: Yuko Omori, et al.
Pubblicazione: (2024)

Integrating artificial intelligence ( AI ) into colorectal cancer reporting
di: Konstantin Bräutigam, et al.
Pubblicazione: (2026)

TRKing down drug resistance in NTRK fusion‐positive cancers†
di: Abigail G Parrish, et al.
Pubblicazione: (2024)

The emerging role of targeted protein degradation to treat and study cancer
di: Maximillian H Brodermann, et al.
Pubblicazione: (2024)

BMP signalling in colorectal cancer: losing the yin to WNTs yang
di: Eloise Clarkson, et al.
Pubblicazione: (2025)

Correction to ‘ CC chemokine receptor‐like 1 functions as a tumour suppressor by impairing CCR7 ‐related chemotaxis in hepatocellular carcinoma’
Pubblicazione: (2025)

A Tc1‐ and Th1‐T‐lymphocyte‐rich tumor microenvironment is a hallmark of MSI colorectal cancer
di: Zhihao Huang, et al.
Pubblicazione: (2025)

Extracellular matrix remodeling as a unique mechanism of expansion of periprostatic adipose tissue: implication for prostate cancer aggressiveness
di: David Estève, et al.
Pubblicazione: (2026)

AI ‐guided histopathology predicts brain metastasis in lung cancer patients
di: Haowen Zhou, et al.
Pubblicazione: (2024)

Roles of THBS2 + fibroblasts in malignant transformation of colorectal polyp to cancer
di: Qizheng Han, et al.
Pubblicazione: (2026)

Correction to ‘Dual inhibition of the endothelin and angiotensin receptor ameliorates renal and inner ear pathologies in Alport mice’
Pubblicazione: (2025)